Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Browse archives for older articles from 2016, 2015, 2014 (all articles may be found in search)

Did you know how medwireNews writes our articles?

Filter

Date Title Topic
19 Sep 2018 Atezolizumab ‘Well Tolerated’ By Metastatic Triple-Negative Breast Cancer Patients Breast Cancer - Immunotherapy
18 Sep 2018 Immune Checkpoint Inhibitor Fatal Toxic Events ‘Uncommon’ Immunotherapy - Complications/Toxicities of treatment
17 Sep 2018 ‘Encouraging’ Early Results For Trabectedin Plus Olaparib In Soft-Tissue Sarcoma Cytotoxic agents - Clinical research - Soft Tissue Sarcomas
14 Sep 2018 Preliminary Findings Suggest Potential Role For Camrelizumab In Nasopharyngeal Carcinoma Cytotoxic agents - Immunotherapy - Head and Neck Cancers
13 Sep 2018 TAILOR Supports Cetuximab–FOLFOX-4 For RAS Wild-Type Metastatic Colorectal Cancer Cytotoxic agents - Colon and Rectal Cancer
12 Sep 2018 Busulfan–Melphalan Plus ASCT ‘Important Addition’ For High-Risk Ewing Sarcoma Care Cytotoxic agents - Cancers in Adolescents and Young Adults (AYA) - Sarcoma - Bone Sarcomas
11 Sep 2018 Concurrent Neoadjuvant Chemo-Trastuzumab Offers No Extra Benefit For HER2-Positive Breast Cancer Cytotoxic agents - Breast Cancer - Personalised/Precision medicine
10 Sep 2018 NSCLC Hyperprogression Linked To Immune Checkpoint Inhibitor Use Immunotherapy - Non-small-cell lung cancer
07 Sep 2018 Rituximab Combination Efficacy Equal For First-Line Advanced Follicular Lymphoma Cytotoxic agents - Haematologic Malignancies - Lymphomas
06 Sep 2018 Axillary Surgery Omission May Be Feasible After Neoadjuvant Chemo For Some Breast Cancer Patients Breast Cancer - Surgical oncology
05 Sep 2018 Nivolumab, Nivolumab Plus Ipilimumab ‘Supported’ For Western Refractory Oesophagogastric Cancer Patients Immunotherapy - Oesophageal Cancer - Gastric Cancer
04 Sep 2018 Dual EGFR–MET inhibitor Therapy ‘Promising’ For Advanced Mutated NSCLC Non-small-cell lung cancer - Personalised/Precision medicine - Therapy
03 Sep 2018 Nab-Paclitaxel Plus Gemcitabine Could Be An Option For Advanced Cholangiocarcinoma Cytotoxic agents - Hepatobiliary Cancers - Therapy
31 Aug 2018 Neoadjuvant Dose-Dense MVAC May Improve Bladder Cancer Outcomes Cytotoxic agents - Genitourinary Cancers - Urothelial Cancers - Therapy
30 Aug 2018 Osimertinib Reduces CNS Progression Risk In Advanced EGFR Mutation-Positive NSCLC Non-small-cell lung cancer - Personalised/Precision medicine - Therapy